Malizzo Michael F MD is categorized under Family Practice Doctors in Albuquerque, NM and active since 2010.
Malizzo Michael F MD was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Malizzo at the company’s single location by writing to 5310 Homestead Road Ne Building 4, Albuquerque, New Mexico NM 87110 or by phoning (505) 256-3648. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Malizzo Michael F MD |
| Contact Person: | Michael Malizzo |
| Address: | 5310 Homestead Road Ne Building 4, Albuquerque, New Mexico 87110 |
| Phone Number: | (505) 256-3648 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Malizzo Michael F MD was started in 2010 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael Malizzo for inquiries that concern Malizzo Michael F MD by calling the company number (505) 256-3648, as your correspondence is most welcome. Additionally, the physical location of the single location of Malizzo Michael F MD can be found at the coordinates 35.129002,-106.585788 as well as the street address 5310 Homestead Road Ne Building 4 in Albuquerque, New Mexico 87110.
For its online presence, you may visit Malizzo Michael F MD’s website at and engage with its social media outlets through on Twitter and on Facebook.